David Schmidt G.'s most recent trade in Astrana Health Inc. was a trade of 14,409 Common Stock done at an average price of $49.8 . Disclosure was reported to the exchange on Aug. 14, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Astrana Health Inc. | David G. Schmidt | Director | Sale or transfer of securities back to the company at price $ 49.76 per share. | 14 Aug 2024 | 14,409 | 9,314 (0%) | 0% | 49.8 | 716,992 | Common Stock |
Astrana Health Inc. | David G. Schmidt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2024 | 11,000 | 0 | - | - | Stock Option (right to buy) | |
Astrana Health Inc. | David G. Schmidt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.35 per share. | 14 Aug 2024 | 11,000 | 20,314 (0%) | 0% | 15.4 | 168,850 | Common Stock |
Astrana Health Inc. | David G. Schmidt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2024 | 3,409 | 0 | - | - | Stock Option (right to buy) | |
Astrana Health Inc. | David G. Schmidt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.41 per share. | 14 Aug 2024 | 3,409 | 23,723 (0%) | 0% | 18.4 | 62,760 | Common Stock |
Astrana Health Inc. | David G. Schmidt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 3,564 | 9,314 (0%) | 0% | 0 | Common Stock | |
Apollo Medical Holdings Inc | Schmidt David G. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 5,750 | 5,750 (0%) | 0% | 0 | Common Stock | |
Apollo Medical Holdings Inc | David Schmidt G. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.11 per share. | 06 Dec 2023 | 7,500 | 7,500 (0%) | 0% | 18.1 | 135,825 | Common Stock |
Apollo Medical Holdings Inc | David G. Schmidt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 7,500 | 0 | - | - | Stock Option (right to buy) | |
Apollo Medical Holdings Inc | Schmidt David G. | Director | Sale or transfer of securities back to the company at price $ 33.49 per share. | 06 Dec 2023 | 7,500 | 0 (0%) | 0% | 33.5 | 251,175 | Common Stock |
Apollo Medical Holdings Inc | David G. Schmidt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
Apollo Medical Holdings Inc | David G. Schmidt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.20 per share. | 17 Aug 2021 | 40,000 | 40,000 (0%) | 0% | 5.2 | 208,000 | Common Stock |
Apollo Medical Holdings Inc | David G. Schmidt | Director | Sale of securities on an exchange or to another person at price $ 73.67 per share. | 17 Aug 2021 | 40,000 | 0 (0%) | 0% | 73.7 | 2,946,800 | Common Stock |
Apollo Medical Holdings Inc | David G. Schmidt | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2021 | 40,000 | 0 | - | - | Stock Option (right to buy) | |
Apollo Medical Holdings Inc | David G. Schmidt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |